title: Comments on the original article by Soubrier et al. "Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis".
authors.forename: Bruno
authors.initials: B
authors.lastname: Seriolo
authors.forename: Sabrina
authors.initials: S
authors.lastname: Paoliono
authors.forename: Carmela
authors.initials: C
authors.lastname: Ferrone
authors.forename: Maurizio
authors.initials: M
authors.lastname: Cutolo
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D050197:Atherosclerosis / Q000517:prevention & control; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D011446:Prospective Studies; D012720:Severity of Illness Index; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D008055:Lipids; D014409:Tumor Necrosis Factor-alpha